Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Autologous CD133-Positive BTSC mRNA-Pulsed Autologous Dendritic Cell Vaccine

Known as: Autologous CD133-Positive Brain Tumor Stem Cell mRNA-Pulsed Autologous Dendritic Cell Vaccine 
A cancer vaccine consisting of autologous dendritic cells (DCs) loaded with CD133-positive autologous brain tumor stem cells (BTSCs) -derived mRNA… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Failure to eradicate cancer stem cells (CSC) during primary therapy may lead to cancer recurrence. We recently reported that… Expand
2017
2017
BackgroundCD133-positive cells in hepatocellular carcinoma (HCC) exhibit cancer stem cell (CSC)-like properties as well as… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2017
2017
OBJECTIVE Defects in the apoptotic machinery and augmented survival signals contribute to drug resistance in glioblastoma (GBM… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2016
2016
There is increasing evidence supporting the cancer stem cell (CSC) hypothesis, which suggests that a population of tumor cells… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
2016
2016
Purpose Due to their minimal-invasive yet potentially current character circulating tumor cells (CTC) might be useful as a… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
2013
2013
Glioblastoma multiforme (GBM) is the most common primary brain tumor, with a median survival of only 15 months. A subpopulation… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2012
2012
In addition to intrinsic regulatory mechanisms, brain tumor stemlike cells (BTSCs), a small subpopulation of malignant glial… Expand
Highly Cited
2009
Highly Cited
2009
Hypoxia contributes to the progression of a variety of cancers by activating adaptive transcriptional programs that promote cell… Expand
2009
2009
BackgroundCD133 was detected in several types of cancers including hepatocellular carcinoma (HCC), which raised the possibility… Expand
  • table 1
  • table 2
  • table 3
Highly Cited
2007
Highly Cited
2007
The presence of a CD133+/nestin+ population in brain tumors suggests that a normal neural stem cell may be the cell of origin for… Expand